Skip to main content

Day: May 16, 2023

NurExone Granted U.S. Patent for Technology and Drug Composition of Exo-PTEN, Designed for Treating Acute Spinal Cord Injuries

TORONTO and TEL AVIV, Israel, May 16, 2023 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (the “Company” or “NurExone“) (TSXV: NRX) (FSE: J90) (NRX.V), a biopharmaceutical company developing biologically-guided exosome therapy for patients with traumatic spinal cord injuries, announces that the Company has received an issue notification from the United States Patent and Trademark Office (“USPTO”) for U.S. Patent NO. 11,648,260, granted for the period of 20 years from filing date until March 27, 2039. The patent protects NurExone’s Exo-PTEN technology, and its drug composition as well as methods for non-invasive intranasal administration of exosome-based treatment. The Patent is a result of a productive collaboration between the Technion (the Israel Institute of Technology) and Tel Aviv University. Both Technology...

Continue reading

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within The Pain and Rehabilitation Medical Group in Torrance, California

Follows successful evaluation by Dr. Fabian Proano, MD including complex thoracic procedures ROSELAND, N.J., May 16, 2023 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery systems that provide painless and precise injections, today announced that it has commenced sales of CompuFlo® Epidural disposables into The Pain and Rehabilitation Medical Group in Torrance, California. Adoption of the technology by this clinic follows a successful evaluation process by its founder, Dr. Fabian Proano, an interventional pain medicine physician, who is board-certified by the American Board of Anesthesiology in both anesthesiology and pain medicine. Dr. Proano initially conducted eight cases using the CompuFlo Epidural system, in which he reported 100% success. The evaluation included Epidural...

Continue reading

Lincoln Tech Announces Planned Opening of Hunter Training Center at Their Denver, CO Campus

Collaboration with Hunter Engineering expands career opportunities for students, offers training to local shop techs; Lincoln Tech will become first school nationwide to receive exclusive Hunter heavy-duty truck lift. Parsippany, NJ, May 16, 2023 (GLOBE NEWSWIRE) — Lincoln Educational Services Corporation (NASDAQ: LINC), a national leader in specialized technical training for more than 75 years, has announced a new collaboration with Hunter Engineering, the leading name in the undercar service industry. Lincoln Tech’s Denver campus will become the latest site to house a Hunter Training Center, where students can train directly on patented Hunter equipment. Local repair shops will also have the opportunity to send technicians to Lincoln Tech to take advantage of the equipment at the campus. The Grand Opening of the Hunter Training...

Continue reading

Dorel Industries Inc. Announces Virtual Annual Meeting of Shareholders

Wednesday, May 24, 2023 at 10:00 A.M. MONTREAL, May 16, 2023 (GLOBE NEWSWIRE) — Shareholders are invited to participate by live audio webcast at https://www.dorel.com/pages/shareholder-information Shareholders will have the ability to interact with Dorel Industries Inc. Senior Management by submitting questions to ir@dorel.com. To be sure your questions are addressed during the Q&A portion of the annual meeting, it is recommended that you submit them no later than 5 p.m. on Friday, May 19, 2023. Dorel Industries Inc. (TSX: DII.B, DII.A) is a global organization, operating two distinct businesses in juvenile products and home products. Dorel’s strength lies in the diversity, innovation and quality of its products as well as the superiority of its brands. Dorel Juvenile’s powerfully branded products include global brands Maxi-Cosi,...

Continue reading

Cellebrite and The Exodus Road Provide Digital Intelligence Technology to the National Bureau of Investigations Anti-Human Trafficking Division in the Philippines

As the digital world enables the spread of human trafficking and exploitation, Cellebrite empowers law enforcement with advanced digital intelligence in support of their efforts to outsmart online criminal activity and secure justice for survivors of exploitation. PETAH TIKVA, Israel and TYSONS CORNER, Va. and COLORADO SPRINGS, Colo., May 16, 2023 (GLOBE NEWSWIRE) — Cellebrite DI Ltd. (Nasdaq: CLBT), a global leader in Digital Intelligence (DI) solutions for the public and private sectors, and The Exodus Road, an international nonprofit organization disrupting human trafficking, announced today that they are providing digital intelligence technology to ensure the National Bureau of Investigations (NBI) Anti-Human Trafficking Division in the Philippines has the capacity to accelerate justice in cases of exploitation. Cellebrite...

Continue reading

Skyward Specialty Adds Anthony J. Kuczinski to Board of Directors

HOUSTON, May 16, 2023 (GLOBE NEWSWIRE) — Skyward Specialty Insurance Group Inc.TM (NASDAQ: SKWD) (“Skyward Specialty” or “the Company”), a leader in the specialty property and casualty market, is pleased to announce the addition of Anthony J. Kuczinski to its Board of Directors effective August 1, 2023. With more than 38 years of industry expertise, Kuczinski adds unmatched knowledge and experience to the Skyward Specialty board. Widely recognized through the insurance industry for his ability to drive long-term profitable growth, Kuczinski spent 34 years at Munich Re, serving as President and Chief Executive Officer for 15 years of Munich Reinsurance US Holdings. In addition to his storied career at Munich Re, Kuczinski has assumed numerous leadership positions on the boards of key industry organizations,...

Continue reading

QSAM Biosciences and RLS Announce Clinical and Commercial Supply Agreement for Promising Clinical-Stage Metastatic and Primary Bone Cancer Treatment, CycloSam®

Partnership is Latest in Series of RLS Efforts to Expand Industry-Leading CDMO Business and Clinical Trial Capability with Radiopharmaceutical Partners Across U.S. Austin, TX and Lake Zurich, IL, May 16, 2023 (GLOBE NEWSWIRE) — QSAM Biosciences, Inc. (OTCQB: QSAM), a clinical stage biotechnology company developing next-generation therapeutic radiopharmaceuticals, and RLS (USA) Inc., the third-largest nuclear medicine pharmacy network in the U.S., announced today a commercial supply and clinical dose preparation agreement for the therapeutic radiopharmaceutical drug candidate CycloSam® (Samarium-153 DOTMP), a promising clinical-stage treatment for metastatic and primary bone cancer in adults and children. QSAM is actively enrolling patients with metastatic bone cancer in a Phase I clinical trial for CycloSam® across three clinical...

Continue reading

Ikano Bank Digitalizes with NETSOL’s NFS Ascent & Digital Platforms

Alongside Northern Europe, NFS Ascent is already live in North America, Asia-Pacific and the UK ENCINO, Calif., May 16, 2023 (GLOBE NEWSWIRE) — NETSOL Technologies, Inc. (Nasdaq: NTWK), a global business services and enterprise application solutions provider, announced the go-live of its next-generation solution NFS Ascent for Ikano Bank – a Swedish bank operating across the Nordic and European regions. NETSOL’s NFS Ascent and suite of digital solutions are being implemented on the Cloud to support Ikano Bank’s lending to businesses. “The partnership with Ikano Bank is a significant project for NETSOL Europe representing the largest multi-country roll-out of our premier platform NFS Ascent. This engagement contributes to a multi-million-euro partnership for the Nordic region and beyond,” said Asad Ghauri, President Asia-Pacific...

Continue reading

SAB Biotherapeutics Provides Company Update for Q1 2023 Financial Results

SIOUX FALLS, S.D., May 16, 2023 (GLOBE NEWSWIRE) — SAB Biotherapeutics (Nasdaq: SABS), (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human immunoglobulins (hIgG), also known as fully-human polyclonal antibodies, without the need for human donors, yesterday reported financial results for the first quarter ended March 31, 2023, and provided a company update. “Our first quarter 2023 results demonstrate that we continue to execute on our strategy to develop and deliver powerful immunotherapeutic treatments to patients with significant unmet needs. We recently announced Breakthrough Therapy Designation and Fast Track designation for SAB-176 from the FDA further validating the potential of our immunotherapy platform to treat a wide...

Continue reading

NNN REIT, Inc. (NYSE:NNN) President and CEO Steve Horn Interviewed by Advisor Access

NNN REIT (NYSE:NNN): 33 Years of Annual Dividend Increases SAN FRANCISCO, May 16, 2023 (GLOBE NEWSWIRE) — NNN REIT, Inc. (NYSE: NNN), a real estate investment trust, invests primarily in high-quality retail properties subject to long-term leases. As of March 31, 2023, the company owned 3,449 properties in 49 states with a gross leasable area of approximately 35.3 million square feet and with a weighted average remaining lease term of 10.3 years. Click to view the NNN REIT Fact Sheet Click to view the NNN REIT Investor Presentation Click to visit the NNN REIT Website President and CEO Steve Horn talks to Advisor Access about the company’s strategy that has led to 33 successive years of dividend growth. Advisor Access: Your company announced its name change to NNN REIT, Inc. What brought about the change? Steve Horn: I’m excited...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.